Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Feb 04, 2022 10:45am
115 Views
Post# 34397478

RE:RE:RE:RE:RE:RE:Warrant Extension

RE:RE:RE:RE:RE:RE:Warrant ExtensionThe warrants that are being extended are some of those that are expiring in 2022.  These are not the tradeable  szls.wt or szls.ws warrants.  Those don't expire until June 2023 and Dec 2023 respectively.

This is a good sign.  No risk and when the share price increases above the warrant price the warrants will be purchased adding cash to the coffers.  A better way than going for another round of financing if the company feels the share price is going to exceed those levels in the short term.



MarketMoney wrote: Also if you look at the shareprice vs the warrants........it's more cheaper to buy the stock than the warrants. Then again, warrant can go beserk and increase just because people wants them...not because it's cheap but because the investor wants them more than the seller wants them sold....That's the market, you never know what going to happen...otherwise it would be too easy lol


<< Previous
Bullboard Posts
Next >>